You just read:

BioMarin Receives Anticipated Notification of PDUFA Extension for Pegvaliase Biologics License Application (BLA) to May 28, 2018

News provided by

BioMarin Pharmaceutical Inc.

Dec 22, 2017, 08:30 ET